Skip to content
Search

Latest Stories

‘It was an unusual story’

by ASJAD NAZIR

Taboo-busting TV serial Shakti – Astitva Ke Ehsaas Ki has been one of the biggest success stories from the past decade and integral to that has been the path-breaking role played by Rubina Dilaik.


After more than 900 episodes, the acclaimed actress has quit the serial, but left an impressive legacy and inspired everyone from writers to actors to think out of the box.

Eastern Eye caught up with Rubina to talk about her time on a series that transformed television and her future plans.

When you took on the role in Shakti – Astitva Ke Ehsaas Ki did you expect it to make an impact?

Honestly, I prayed it did, but wasn’t sure. It was such a risk that the first few months really felt as if I was walking on eggshells.

Why do you think the serial has been successful?

There are various reasons, including it being a unique concept, which was never experimented with on Indian TV. My character, Saumya, was that of an intersex, yet the role was written so well, that everyone could relate to her life. The audience welcomed the storytelling with such open arms that the creators were encouraged to explore further in the story.

What has been your fondest memory of working on the show?

The entire journey has been so incredible that it will remain with me for the rest of my life. I have been on this crazy rollercoaster and don’t have any regrets.

What was the most challenge part of the role?

The biggest challenge was the character itself. It was an unusual story with little facts known about the third gender (especially in our society). I had to unlearn everything and work with a fresh attitude and raw state of mind.

How do you stay motivated when you are doing so many episodes on a popular show?

On a show, there are at least 200 people employed. It’s a source of income for hundreds of families. Any content driven show gives hope to its audience and many creative minds work on it. And Shakti was all of this. I was motivated every single day because I was grateful for everything my show had to offer.

Was it a difficult decision to leave and what made you want to?

It was difficult to part ways with a show that had become a second home. With a generation leap happening, the reins were no more in my hands. I am a challenge driven personality and have to be on the driving seat to ensure my full commitment to any endeavour. With Shakti, I took responsibility for my mistakes, shared success with my team and my each day was filled with purpose because I was doing a project that I cared about.

What is the next plan?

These days I am taking life as it is happening, and soon I am going on a sabbatical to recalibrate my mental, physical and spiritual health.

What’s your dream role?

I want to do a biopic on Kalpana Chawla. She was my hero in school, and I was fascinated by aeronautics and astronomy. I wish that if I couldn’t study then I can at least live my dream now.

What do you enjoy watching on TV?

I enjoy watching reality shows on TV.

What inspires you most?

Reaching out to millions and taking them on a journey with a character is the most inspiring aspect of being an actor.

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
London temple project for Shree Banke Bihari launched

London temple project for Shree Banke Bihari launched

Mahesh Liloriya

The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.

The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”

Keep ReadingShow less
Dickie and Watt

Dickie and Watt launched BrewDog at the age of 24

Getty Images

BrewDog co-founder Martin Dickie leaves after 17 years as James Watt steps back

Highlights:

  • Martin Dickie has announced his departure from BrewDog and the alcohol industry.
  • He co-founded the Ellon-based brewer with James Watt in 2007.
  • Dickie cited family time and personal reasons for his exit.
  • His departure follows recent bar closures as part of a company restructuring.
  • BrewDog confirmed no further leadership changes will follow.

BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.

Early beginnings

Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.

Keep ReadingShow less